Table 4.

Participants with grade 3–4 toxicity at weeks 0–16 after stent insertion

	Usual caregroup (n=102)	External beam radiotherapy group (n=97)
Fatigue	19 (19%)	22 (23%)
Dysphagia	11 (11%)	9 (9%)
Anaemia	10 (10%)	6 (6%)
Anorexia	7 (7%)	9 (9%)
Stent-related pain	6 (6%)	8 (8%)
Nausea	5 (5%)	7 (7%)
Vomiting	4 (4%)	11 (11%)
Upper gastrointestinal haemorrhage	4 (4%)	2 (2%)
Thromboembolic event	3 (3%)	4 (4%)
Bronchopulmonary infection	3 (3%)	3 (3%)
Abdominal pain	2 (2%)	5 (5%)
Oesophageal reflux	2 (2%)	1 (1%)
Dyspepsia	2 (2%)	1 (1%)
Oesophagitis	2 (2%)	0
Abdominal distension	1 (1%)	1 (1%)
Mucositis	1 (1%)	1 (1%)
Fever	1 (1%)	0
Gastritis	1 (1%)	0
Aspiration	0	2 (2%)
Oesophageal fistula	0	1 (1%)*

Data are n (%).

^*Detected after stent insertion and participant retained in all analyses.